XYOSTED 75 mg/0.5 mL Price

Overview

Welcome to Dwaey, specifically on XYOSTED 75 mg/0.5 mL Injection /Solution for page.
This medicine contains an important and useful components, as it consists of Testosterone enanthate.
XYOSTED 75 mg/0.5 mL is available in the market in concentration 75 mg /0.5 ml and in the form of Injection /Solution for.

ANTARES PHARMA INC. is the producer of XYOSTED 75 mg/0.5 mL and it is imported from USA, The most popular alternatives of XYOSTED 75 mg/0.5 mL are listed downward .

Mode Of Action

Testosterone is the principal endogenous androgen responsible for promoting the growth and development of male sexual organs and maintaining secondary sex characteristics in androgen-deficient males.

Indication

• Inoperable metastatic breast cancer
• Delayed puberty
• Male hypogonadism

Precaution

Cardiovascular disorders, skeletal metastases, renal or hepatic impairment, epilepsy, migraine, diabetes or other conditions which may be aggravated by fluid retention, eg heart failure. Elderly, prepubertal boys. Monitor signs of virilization (females) and development of priapism or excessive sexual stimulation (males). Periodic haemoglobin, lipid determinations and rectal prostate examination. Lactation: Drug is excreted into breast milk; avoid using

Side Effects

• Fluid and electrolyte retention; increased vascularity of the skin; hypercalcaemia
• impaired glucose tolerance; increased bone growth and skeletal weight; increase LDL cholesterol; increase haematocrit and fibrinolytic activity; headache
• depression and GI bleeding. Males: spermatogenesis suppression
• priapism
• gynaecomastia
• prostatic hyperplasia and accelerate growth of malignant prostate neoplasms. Females: suppression of lactation
• ovarian activity and menstruation; virilization
• clitoris hypertrophy
• increased libido
• oily skin
• acne
• hirsutism
• male pattern baldness. Children: Closure of the epiphyses and stop linear growth in early puberty
• symptoms of virilisation. Precocious sexual development
• increased frequency of erection in boys
• and clitoral enlargement in girls. IM: urticaria
• inflammation at Inj site
• postinjection induration
• furunculosis. Potentially Fatal: Peliosis hepatis
• liver toxicity
• malignant neoplasm.

Contra indication

Hypercalcaemia or hypercalciuria, males with breast or prostate carcinoma. Pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.